Humira Purple Book BLA 125057
- BLA number
- 125057
- Proprietary names
- Humira
- Proper names
- adalimumab
- Applicant
- AbbVie Inc.
- Center
- CDER
- First observed release
- 2020-02-01
- Latest observed release
- 2026-06-01
- Newest archive release
- 2026-06-01
- FDA patent list
- 66 patents listed; source updated 2025-06-11
- Coverage
- Present in newest release
Latest Known Product Presentations#
Product, Proprietary name, Proper name table| Product | Proprietary name | Proper name | License type | Strength | Dosage form | Route | Presentation | Marketing | Licensure | Approval | Patent list provided |
|---|
| 001 | Humira | adalimumab | 351(a) | 40MG/0.8ML | Injection | Subcutaneous | Autoinjector | Rx | Licensed | 2002-12-31 | YES |
| 002 | Humira | adalimumab | 351(a) | 40MG/0.8ML | Injection | Subcutaneous | Pre-Filled Syringe | Rx | Licensed | 2002-12-31 | YES |
| 003 | Humira | adalimumab | 351(a) | 20MG/0.4ML | Injection | Subcutaneous | Pre-Filled Syringe | Disc* | Licensed | 2008-02-21 | YES |
| 004 | Humira | adalimumab | 351(a) | 40MG/0.8ML | Injection | Subcutaneous | Single-Dose Vial | Disc* | Licensed | 2013-04-24 | YES |
| 005 | Humira | adalimumab | 351(a) | 10MG/0.2ML | Injection | Subcutaneous | Pre-Filled Syringe | Disc* | Licensed | 2014-09-23 | YES |
| 006 | Humira | adalimumab | 351(a) | 40MG/0.4ML | Injection | Subcutaneous | Pre-Filled Syringe | Rx | Licensed | 2015-11-23 | YES |
| 007 | Humira | adalimumab | 351(a) | 40MG/0.4ML | Injection | Subcutaneous | Autoinjector | Rx | Licensed | 2016-03-09 | YES |
| 008 | Humira | adalimumab | 351(a) | 80MG/0.8ML | Injection | Subcutaneous | Pre-Filled Syringe | Rx | Licensed | 2016-10-17 | YES |
| 009 | Humira | adalimumab | 351(a) | 80MG/0.8ML | Injection | Subcutaneous | Autoinjector | Rx | Licensed | 2017-04-21 | YES |
| 010 | Humira | adalimumab | 351(a) | 20MG/0.2ML | Injection | Subcutaneous | Pre-Filled Syringe | Rx | Licensed | 2017-04-28 | YES |
| 011 | Humira | adalimumab | 351(a) | 10MG/0.1ML | Injection | Subcutaneous | Pre-Filled Syringe | Rx | Licensed | 2017-04-28 | YES |
Biosimilar And Interchangeable Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 761024 | Amjevita | adalimumab-atto | 351(k) Interchangeable | Rx | 2026-06-01 |
| 761058 | Cyltezo | adalimumab-adbm | 351(k) Interchangeable | Rx | 2026-06-01 |
| 761059 | Hadlima | adalimumab-bwwd | 351(k) Interchangeable | Rx | 2026-06-01 |
| 761071 | Hyrimoz | adalimumab-adaz | 351(k) Interchangeable | Rx | 2026-06-01 |
| 761118 | Abrilada | adalimumab-afzb | 351(k) Interchangeable | Rx | 2026-06-01 |
| 761154 | Hulio | adalimumab-fkjp | 351(k) Interchangeable | Rx | 2026-06-01 |
| 761216 | Yusimry | adalimumab-aqvh | 351(k) Biosimilar | Rx | 2026-06-01 |
| 761219 | Yuflyma | adalimumab-aaty | 351(k) Interchangeable | Rx | 2026-06-01 |
| 761255 | Idacio | adalimumab-aacf | 351(k) Biosimilar | Rx | 2026-06-01 |
| 761299 | Simlandi | adalimumab-ryvk | 351(k) Interchangeable | Rx | 2026-06-01 |
Published Patent List#
Patent, Expiration, Source updated table| Patent | Expiration | Source updated |
|---|
| 9,550,826 | 2034-11-14 | 2025-06-11 |
| 9,499,614 | 2034-03-14 | 2025-06-11 |
| 9,150,645 | 2033-05-13 | 2025-06-11 |
| 9,266,949 | 2033-05-13 | 2025-06-11 |
| 9,315,574 | 2033-04-21 | 2025-06-11 |
| 9,085,618 | 2033-03-14 | 2025-06-11 |
| 9,181,337 | 2033-03-14 | 2025-06-11 |
| 9,181,572 | 2033-03-14 | 2025-06-11 |
| 9,290,568 | 2033-03-14 | 2025-06-11 |
| 9,334,319 | 2033-03-14 | 2025-06-11 |
| 9,346,879 | 2033-03-14 | 2025-06-11 |
| 9,359,434 | 2033-03-14 | 2025-06-11 |
| 9,499,616 | 2033-03-14 | 2025-06-11 |
| 9,708,400 | 2033-03-14 | 2025-06-11 |
| 9,062,106 | 2032-04-26 | 2025-06-11 |
| 9,090,688 | 2032-04-26 | 2025-06-11 |
| 9,505,834 | 2032-04-26 | 2025-06-11 |
| 9,522,953 | 2032-04-26 | 2025-06-11 |
| 9,683,033 | 2032-04-26 | 2025-06-11 |
| 9,957,318 | 2032-04-26 | 2025-06-11 |
| 8,708,968 | 2032-01-24 | 2025-06-11 |
| 9,339,610 | 2032-01-24 | 2025-06-11 |
| 9,624,295 | 2031-03-31 | 2025-06-11 |
| 8,999,337 | 2031-02-06 | 2025-06-11 |
| 8,420,081 | 2030-01-13 | 2025-06-11 |
| 11,167,030 | 2028-11-28 | 2025-06-11 |
| 11,191,834 | 2028-11-28 | 2025-06-11 |
| 9,085,619 | 2028-11-28 | 2025-06-11 |
| 9,284,370 | 2028-06-10 | 2025-06-11 |
| 9,669,093 | 2028-06-10 | 2025-06-11 |
| 8,889,136 | 2027-10-09 | 2025-06-11 |
| 8,663,945 | 2027-09-13 | 2025-06-11 |
| 8,906,646 | 2027-09-13 | 2025-06-11 |
| 8,911,964 | 2027-09-13 | 2025-06-11 |
| 9,090,867 | 2027-09-13 | 2025-06-11 |
| 9,234,032 | 2027-09-13 | 2025-06-11 |
| 9,284,371 | 2027-09-13 | 2025-06-11 |
| 8,715,664 | 2027-07-24 | 2025-06-11 |
| 8,926,975 | 2027-06-08 | 2025-06-11 |
| 11,083,792 | 2027-04-04 | 2025-06-11 |
| 8,231,876 | 2027-04-04 | 2025-06-11 |
| 8,883,156 | 2027-04-04 | 2025-06-11 |
| 8,895,009 | 2027-04-04 | 2025-06-11 |
| 8,906,372 | 2027-04-04 | 2025-06-11 |
| 8,916,153 | 2027-04-04 | 2025-06-11 |
| 9,096,666 | 2027-04-04 | 2025-06-11 |
| 9,102,723 | 2027-04-04 | 2025-06-11 |
| 9,273,132 | 2027-04-04 | 2025-06-11 |
| 9,328,165 | 2027-04-04 | 2025-06-11 |
| 9,913,902 | 2027-04-04 | 2025-06-11 |
| 8,808,700 | 2026-05-16 | 2025-06-11 |
| 8,961,973 | 2025-04-11 | 2025-06-11 |
| 8,961,974 | 2025-04-11 | 2025-06-11 |
| 8,986,693 | 2025-04-11 | 2025-06-11 |
| 9,061,005 | 2025-04-11 | 2025-06-11 |
| 9,187,559 | 2025-04-11 | 2025-06-11 |
| 9,512,216 | 2025-04-11 | 2025-06-11 |
| 8,906,373 | 2023-07-18 | 2025-06-11 |
| 9,067,992 | 2023-07-18 | 2025-06-11 |
| 9,085,620 | 2023-07-18 | 2025-06-11 |
| 9,090,689 | 2023-07-18 | 2025-06-11 |
| 6,805,686 | 2023-05-06 | 2025-06-11 |
| 8,911,737 | 2022-06-05 | 2025-06-11 |
| 8,974,790 | 2022-06-05 | 2025-06-11 |
| 8,992,926 | 2022-06-05 | 2025-06-11 |
| 9,546,212 | 2022-06-05 | 2025-06-11 |
Official Monthly Change Events#
Release, Event, Product table| Release | Event | Product | Name | License type | Status | Applicant |
|---|
| 2026-04-01 | U | 004 | Humira | 351(a) | Disc* | AbbVie Inc. |
| 2025-05-01 | U | 004 | Humira | 351(a) | Disc | AbbVie Inc. |
| 2024-11-01 | U | 003 | Humira | 351(a) | Disc* | AbbVie Inc. |
| 2024-11-01 | U | 005 | Humira | 351(a) | Disc* | AbbVie Inc. |
| 2022-06-01 | U | 003 | Humira | 351(a) | Disc | AbbVie Inc. |
| 2022-06-01 | U | 005 | Humira | 351(a) | Disc | AbbVie Inc. |
| 2021-06-01 | U | 001 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-06-01 | U | 002 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-06-01 | U | 003 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-06-01 | U | 004 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-06-01 | U | 005 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-06-01 | U | 006 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-06-01 | U | 007 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-06-01 | U | 008 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-06-01 | U | 009 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-06-01 | U | 010 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-06-01 | U | 011 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-05-01 | U | 001 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-05-01 | U | 002 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-05-01 | U | 003 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-05-01 | U | 004 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-05-01 | U | 005 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-05-01 | U | 006 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-05-01 | U | 007 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-05-01 | U | 008 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-05-01 | U | 009 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-05-01 | U | 010 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2021-05-01 | U | 011 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2020-08-01 | U | 001 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2020-08-01 | U | 002 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2020-08-01 | U | 003 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2020-08-01 | U | 004 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2020-08-01 | U | 005 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2020-08-01 | U | 006 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2020-08-01 | U | 007 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2020-08-01 | U | 008 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2020-08-01 | U | 009 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2020-08-01 | U | 010 | Humira | 351(a) | Rx | AbbVie Inc. |
| 2020-08-01 | U | 011 | Humira | 351(a) | Rx | AbbVie Inc. |
Observed Product State History#
Release, Product, Name table| Release | Product | Name | License type | Marketing | Licensure | Approval |
|---|
| 2026-04-01 | 004 | Humira | 351(a) | Disc* | Licensed | 2013-04-24 |
| 2025-05-01 | 004 | Humira | 351(a) | Disc | Licensed | 2013-04-24 |
| 2024-11-01 | 003 | Humira | 351(a) | Disc* | Licensed | 2008-02-21 |
| 2024-11-01 | 005 | Humira | 351(a) | Disc* | Licensed | 2014-09-23 |
| 2022-06-01 | 003 | Humira | 351(a) | Disc | Licensed | 2008-02-21 |
| 2022-06-01 | 005 | Humira | 351(a) | Disc | Licensed | 2014-09-23 |
| 2021-06-01 | 001 | Humira | 351(a) | Rx | Licensed | 2002-12-31 |
| 2021-06-01 | 002 | Humira | 351(a) | Rx | Licensed | 2002-12-31 |
| 2021-06-01 | 003 | Humira | 351(a) | Rx | Licensed | 2008-02-21 |
| 2021-06-01 | 004 | Humira | 351(a) | Rx | Licensed | 2013-04-24 |
| 2021-06-01 | 005 | Humira | 351(a) | Rx | Licensed | 2014-09-23 |
| 2021-06-01 | 007 | Humira | 351(a) | Rx | Licensed | 2016-03-09 |
| 2021-06-01 | 008 | Humira | 351(a) | Rx | Licensed | 2016-10-17 |
| 2021-06-01 | 009 | Humira | 351(a) | Rx | Licensed | 2017-04-21 |
| 2021-06-01 | 011 | Humira | 351(a) | Rx | Licensed | 2017-04-28 |
| 2020-05-01 | 001 | Humira | 351(a) | Rx | Licensed | 2017-04-21 |
| 2020-05-01 | 002 | Humira | 351(a) | Rx | Licensed | 2016-10-17 |
| 2020-05-01 | 003 | Humira | 351(a) | Rx | Licensed | 2002-12-31 |
| 2020-05-01 | 004 | Humira | 351(a) | Rx | Licensed | 2016-03-09 |
| 2020-05-01 | 005 | Humira | 351(a) | Rx | Licensed | 2002-12-31 |
| 2020-05-01 | 006 | Humira | 351(a) | Rx | Licensed | 2015-11-23 |
| 2020-05-01 | 007 | Humira | 351(a) | Rx | Licensed | 2008-02-21 |
| 2020-05-01 | 008 | Humira | 351(a) | Rx | Licensed | 2017-04-28 |
| 2020-05-01 | 009 | Humira | 351(a) | Rx | Licensed | 2014-09-23 |
| 2020-05-01 | 010 | Humira | 351(a) | Rx | Licensed | 2017-04-28 |
| 2020-05-01 | 011 | Humira | 351(a) | Rx | Licensed | 2013-04-24 |
| 2020-02-01 | 001 | Humira | 351(a) | Marketed | Licensed | 2017-04-21 |
| 2020-02-01 | 002 | Humira | 351(a) | Marketed | Licensed | 2016-10-17 |
| 2020-02-01 | 003 | Humira | 351(a) | Marketed | Licensed | 2002-12-31 |
| 2020-02-01 | 004 | Humira | 351(a) | Marketed | Licensed | 2016-03-09 |
| 2020-02-01 | 005 | Humira | 351(a) | Marketed | Licensed | 2002-12-31 |
| 2020-02-01 | 006 | Humira | 351(a) | Marketed | Licensed | 2015-11-23 |
| 2020-02-01 | 007 | Humira | 351(a) | Marketed | Licensed | 2008-02-21 |
| 2020-02-01 | 008 | Humira | 351(a) | Marketed | Licensed | 2017-04-28 |
| 2020-02-01 | 009 | Humira | 351(a) | Marketed | Licensed | 2014-09-23 |
| 2020-02-01 | 010 | Humira | 351(a) | Marketed | Licensed | 2017-04-28 |
| 2020-02-01 | 011 | Humira | 351(a) | Marketed | Licensed | 2013-04-24 |